Volume 5 Number 4
Editorials
63
Stent selection in patients on oral anticoagulants: can we
prevent restenosis and avoid bleeding?EuroIntervention 2009;5:405-407
64
Meta-analytic rage or race for evidence-based
interventional cardiology?EuroIntervention 2009;5:409-413
EAPCI column
Clinical research
66
Correlations between epicardial flow, microvascular
reperfusion, infarct size and clinical outcomes in patients
with anterior versus non-anterior myocardial infarction
treated with primary or rescue angioplasty: analysis from
the EMERALD trialNikolsky E, Stone G, Lee E, Lansky A, Webb J, Cox D, Brodie B, Turco M, Rutherford B, Kalynych A, Antoniucci D, Krucoff M, Gibbons R, Fahy M, Mehran R
EuroIntervention 2009;5:417-424
67
Early and late increased bleeding rates after angioplasty
and stenting due to combined antiplatelet and anticoagulant
therapyEuroIntervention 2009;5:425-431
68
Long-term follow-up after drug eluting stent implantation in
left main trifurcationsEuroIntervention 2009;5:432-437
69
Aorto-iliac angiography as a screening tool in selecting
patients for transfemoral aortic valve implantation with the
Edwards SAPIEN bioprosthesisEuroIntervention 2009;5:438-442
70
The recurrence of iatrogenic femoral artery
pseudoaneurysm after occlusion by ultrasound guided
percutaneous thrombin injectionMadaric J, Mistrik A, Vulev I, Liska B, Vozar M, Lederer P, Gocar M, Kozlovska T, Fridrich V, de Bruyne B, Bartunek J
EuroIntervention 2009;5:443-447
71
Comparison of the very long term (>1 year) outcomes of
drug-eluting stents for the treatment of bare-metal and
drug-eluting stent restenosisRibamar Costa J, Sousa A, Moreira A, Alves da Costa R, Cano M, Maldonado G, Campos Neto C, Jardim C, Pavanello R, Sousa J
EuroIntervention 2009;5:448-453
72
Long-term clinical outcome of alternative treatment
strategies for drug-eluting stents restenosis73
Impact of drug eluting stents on the clinical practice of
revascularisation of coronary artery diseasede la Torre-Hernández J, Garcia-Camarero T, Burgos-Palacios V, Ruiz-Lera M, Llano-Cardenal M, Exposito V, Sainz-Laso F, Lee D, Figueroa A, Zueco J
EuroIntervention 2009;5:460-464
74
Assisted circulation using the Tandemheart®, percutaneous
transseptal left ventricular assist device, during
percutaneous aortic valve implantation: the Rotterdam
experienceEuroIntervention 2009;5:465-469
75
A novel strategy for managing clopidogrel-induced adverse
skin reactionsEuroIntervention 2009;5:470-474
Expert review
76
Bifurcation stenting with drug-eluting stents: a systematic
review and meta-analysis of randomised trialsEuroIntervention 2009;5:475-484
77
Directional coronary atherectomy: a time for reflection.
Should we let it go?Cubeddu R, Truong Q, Rengifo-Moreno P, Garcia-Camarero T, Okada D, Kiernan T, Inglessis I, Palacios I
EuroIntervention 2009;5:485-493
78
The use of drug-eluting stents in ST-elevation myocardial
infarctionEuroIntervention 2009;5:494-500
80
Scanning electron microscopic assessment of the
biodegradable coating on expanded biolimus-eluting stentsEuroIntervention 2009;5:505-510
EuroIntervention Tools & Techniques
Technical report
82
Virtual 3 Fr PCI system for complex percutaneous coronary
interventionEuroIntervention 2009;5:515-517
Volume 5 Number 4 has been released thanks to the support of the following partners:
- Abbott Vascular Devices
- Cordis, a Johnson & Johnson company
- Daiichi Sankyo
- Hexacath
- Maquet Cardiovascular
- Medtronic
- Minvasys
- Terumo



